GENZADA PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Jan 2024)
What this means for you
Registered since 24 Jul 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87703407
- Registration number
- 5523316
- Mark type
- Design + words
- Filed
- 30 Nov 2017
- Published for opposition
- 08 May 2018
- Registered
- 24 Jul 2018
- Attorney of record
- C. Blair Barbieri
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Scientific research and development
Owner
- ANKH LIFE SCIENCES LIMITED, DUBLIN 2, IE
- ANKH LIFE SCIENCES LIMITED, DUBLIN 2, IE
- Genzada Pharmaceuticals USA, Inc., Sterling, KS, US
- Genzada Pharmaceuticals USA, Inc., Sterling, KS, US
Prosecution history
- 02 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 24 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 13 Jun 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 May 2018 — PUBLISHED FOR OPPOSITION
- 18 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER